Exogenous fractalkine enhances proliferation of endothelial cells, promotes migration of endothelial progenitor cells and improves neurological deficits in a rat model of ischemic stroke

Neuroscience Letters

Volumn 569, Issue , 2014, Pages 80-84

  Qin, Wenjing ^a   Li, Zhendong ^a   Luo, Shijian ^a   Wu, Rui ^a   Pei, Zhong ^b   Huang, Ruxun ^b  

^a THE FIFTH AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Endothelial cell; Endothelial progenitor cell; Fractalkine; Neovascularization; Stroke

Indexed keywords

EXOGENOUS FRACTALKINE; FRACTALKINE; UNCLASSIFIED DRUG; NEUROPROTECTIVE AGENT; RECOMBINANT PROTEIN;

ADULT; ANGIOGENESIS; ANGIOGENIC ACTIVITY; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL DENSITY; BLOOD VESSEL PARAMETERS; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEOVASCULARIZATION (PATHOLOGY); NERVE CELL; NERVE CELL NECROSIS; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; BRAIN; CELL MOTION; CEREBRAL INFARCTION; DRUG EFFECTS; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; STEM CELL; STROKE; VASCULARIZATION;

ANIMALS; BRAIN; BRAIN ISCHEMIA; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CEREBRAL INFARCTION; CHEMOKINE CX3CL1; ENDOTHELIAL CELLS; INJECTIONS, INTRAVENTRICULAR; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; NEURONS; NEUROPROTECTIVE AGENTS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; STEM CELLS; STROKE;

EID: 84898824315     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2014.03.052     Document Type: Article

References (34)

1. Ergul A., Alhusban A., Fagan S.C. Angiogenesis: a harmonized target for recovery after stroke. Stroke 2012, 43:2270-2274.
2. Hoehn B.D., Palmer T.D., Steinberg G.K. Neurogenesis in rats after focal cerebral ischemia is enhanced by indomethacin. Stroke 2005, 36:2718-2724.
3. Lauro C., Di Angelantonio S., Cipriani R., Sobrero F., Antonilli L., Brusadin V., Ragozzino D., Limatola C. Activity of adenosine receptors type 1 Is required for CX3CL1-mediated neuroprotection and neuromodulation in hippocampal neurons. J. Immunol. 2008, 180:7590-7596.
4. Leventhal C., Rafii S., Rafii D., Shahar A., Goldman S.A. Endothelial trophic support of neuronal production and recruitment from the adult mammalian subependyma. Mol. Cell. Neurosci. 1999, 13:450-464.
5. Re D.B., Przedborski S. Fractalkine: moving from chemotaxis to neuroprotection. Nat. Neurosci. 2006, 9:859-861.
6. Hess D.C., Hill W.D., Martin-Studdard A., Carroll J., Brailer J., Carothers J. Bone marrow as a source of endothelial cells and NeuN-expressing cells after stroke. Stroke 2002, 33:1362-1368.
7. Crola D.S.C., Lamerant-Fayel N., Paprocka M., Mitterrand M., Gosset D., Dus D., Kieda C. Selective human endothelial cell activation by chemokines as a guide to cell homing. Immunology 2009, 126:394-404.
8. Chapman G.A., Moores K., Harrison D., Campbell C.A., Stewart B.R., Strijbos P.J. Fractalkine cleavage from neuronal membranes represents an acute event in the inflammatory response to excitotoxic brain damage. J. Neurosci. 2000, 20:C87.
9. Beck H., Plate K.H. Angiogenesis after cerebral ischemia. Acta Neuropathol 2009, 117:481-496.
10. Memezawa H., Minamisawa H., Smith M.L., Siesjo B.K. Ischemic penumbra in a model of reversible middle cerebral artery occlusion in the rat. Exp. Brain Res. 1992, 89:67-78.
11. Yoshida H., Imaizumi T., Fujimoto K., Matsuo N., Kimura K., Cui X., Matsumiya T., Tanji K., Shibata T., Tamo W., Kumagai M., Satoh K. Synergistic stimulation, by tumor necrosis factor-alpha and interferon-gamma, of fractalkine expression in human astrocytes. Neurosci. Lett. 2001, 303:132-136.
12. Chen J., Li Y., Wang L., Zhang Z., Lu D., Lu M., Chopp M. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 2001, 32:1005-1011.
13. Krupinski J., Kaluza J., Kumar P., Kumar S., Wang J.M. Role of angiogenesis in patients with cerebral ischemic stroke. Stroke 1994, 25:1794-1798.
14. Ryu J., Lee C.W., Hong K.H., Shin J.A., Lim S.H., Park C.S., Shim J., Nam K.B., Choi K.J., Kim Y.H., Han K.H. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia. Cardiovasc. Res. 2008, 78:333-340.
15. Wang J., Ohno-Matsui K., Nakahama K., Okamoto A., Yoshida T., Shimada N., Mochizuki M., Morita I. Amyloid beta enhances migration of endothelial progenitor cells by upregulating CX3CR1 in response to fractalkine, which may be associated with development of choroidal neovascularization. Arterioscler. Thromb. Vasc. Biol. 2011, 31:e11-e18.
16. Bazan J.F., Bacon K.B., Hardiman G., Wang W., Soo K., Rossi D., Greaves D.R., Zlotnik A., Schall T.J. A new class of membrane-bound chemokine with a CX3C motif. Nature 1997, 385:640-644.
17. Harrison J.K., Jiang Y., Chen S., Xia Y., Maciejewski D., McNamara R.K., Streit W.J., Salafranca M.N., Adhikari S., Thompson D.A., Botti P., Bacon K.B., Feng L. Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:10896-10901.
18. Hayakawa K., Pham L.D., Katusic Z.S., Arai K., Lo E.H. Astrocytic high-mobility group box 1 promotes endothelial progenitor cell-mediated neurovascular remodeling during stroke recovery. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:7505-7510.
19. Wei L., Erinjeri J.P., Rovainen C.M., Woolsey T.A. Collateral growth and angiogenesis around cortical stroke. Stroke 2001, 32:2179-2184.
20. Donohue M.M., Cain K., Zierath D., Shibata D., Tanzi P.M., Becker K.J. Higher plasma fractalkine is associated with better 6-month outcome from ischemic stroke. Stroke 2012, 43:2300-2306.
21. Volin M.V., Huynh N., Klosowska K., Reyes R.D., Woods J.M. Fractalkine-induced endothelial cell migration requires MAP kinase signaling. Pathobiology 2010, 77:7-16.
22. Kato N., Yanaka K., Hyodo K., Homma K., Nagase S., Nose T. Stable nitroxide Tempol ameliorates brain injury by inhibiting lipid peroxidation in a rat model of transient focal cerebral ischemia. Brain Res. 2003, 979:188-193.
23. Cipriani R., Villa P., Chece G., Lauro C., Paladini A., Micotti E., Perego C., De Simoni M.G., Fredholm B.B., Eusebi F., Limatola C. CX3CL1 is neuroprotective in permanent focal cerebral ischemia in rodents. J. Neurosci. 2011, 31:16327-16335.
24. Swanson R.A., Morton M.T., Tsao-Wu G., Savalos R.A., Davidson C., Sharp F.R. A semiautomated method for measuring brain infarct volume. J. Cereb. Blood Flow Metab. 1990, 10:290-293.
25. Lee S.J., Namkoong S., Kim Y.M., Kim C.K., Lee H., Ha K.S., Chung H.T., Kwon Y.G., Kim Y.M. Fractalkine stimulates angiogenesis by activating the Raf-1/MEK/ERK- and PI3K/Akt/eNOS-dependent signal pathways. Am. J. Physiol. Heart Circ. Physiol. 2006, 291:H2836-H2846.
26. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., Witzenbichler B., Schatteman G., Isner J.M. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967.
27. Hayashi T., Noshita N., Sugawara T., Chan P.H. Temporal profile of angiogenesis and expression of related genes in the brain after ischemia. J. Cereb. Blood Flow Metab. 2003, 23:166-180.
28. Mizuno T., Kawanokuchi J., Numata K., Suzumura A. Production and neuroprotective functions of fractalkine in the central nervous system. Brain Res. 2003, 979:65-70.
29. Yamashita T., Ninomiya M., Hernandez A.P., Garcia-Verdugo J.M., Sunabori T., Sakaguchi M., Adachi K., Kojima T., Hirota Y., Kawase T., Araki N., Abe K., Okano H., Sawamoto K. Subventricular zone-derived neuroblasts migrate and differentiate into mature neurons in the post-stroke adult striatum. J. Neurosci. 2006, 26:6627-6636.
30. Lin T.N., He Y.Y., Wu G., Khan M., Hsu C.Y. Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats. Stroke 1993, 24:117-121.
31. Fan Y., Yang G.Y. Therapeutic angiogenesis for brain ischemia: a brief review. J. Neuroimmune Pharmacol. 2007, 2:284-289.
32. Wang Z., Tsai L.K., Munasinghe J., Leng Y., Fessler E.B., Chibane F., Leeds P., Chuang D.M. Chronic valproate treatment enhances postischemic angiogenesis and promotes functional recovery in a rat model of ischemic stroke. Stroke 2012, 43:2430-2436.
33. Zhang Z.G., Zhang L., Jiang Q., Chopp M. Bone marrow-derived endothelial progenitor cells participate in cerebral neovascularization after focal cerebral ischemia in the adult mouse. Circ. Res. 2002, 90:284-288.
34. Zhang Z.G., Chopp M. Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic. Lancet Neurol. 2009, 8:491-500.